Invasive aspergillosis (IA) is a major cause of mortality in allogeneic hematopoietic stem cell transplant recipients who develop graft-versus-host disease. Here, we report a patient with a probable pulmonary IA after hematopoietic stem cell transplant on cyclosporine A, mycophenolate mofetil, and corticosteroid therapy for graft-versus-host disease who responded to posaconazole after progression of IA on voriconazole and a consecutive caspofungin treatment.
From the *Departments of Hematology/Oncology and Hemostasiology, †Institute for Medical Microbiolgy and Epidemiology of Infectious Diseases, and ‡Diagnostic Radiology, University of Leipzig, Leipzig, Germany.
Reprints: Agata Mikolajewska, MD, Department of Hematology/Oncology, University of Leipzig, Johannisallee 32A, 04103 Leipzig, Germany. E-mail: Agata.Mikolajewska@medizin.uni-leipzig.de.